IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 16 holdings | $8.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$8.4M164,54796.4%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$50.9K866,7700.6%
United Therapeutics Corp(UTHR)COM91307C102$43.6K294,4290.5%
Bioverativ IncCOM97075E100$39.4K730,2600.5%
Gilead Sciences Inc(GILD)COM375558103$34.2K478,0530.4%
Sucampo PharmaceuticalsCOM864909106$23.4K1,304,3760.3%
Mckesson Corp(MCK)COM58155Q103$19.7K126,4820.2%
Invacare CorpCOM461203101$18.7K1,107,7700.2%
Halyard Health IncCOM40650V100$18.2K395,0150.2%
RTI Surgical IncCOM74975N105$17.8K4,334,8520.2%
Orthofix International NVCOMN6748L102$17.7K324,3570.2%
Amgen Inc(AMGN)COM031162100$15.2K87,4770.2%
Merck & Co. Inc.(MRK)COM58933Y105$9.0K159,4660.1%
Juniper Pharmaceuticals IncCOM48203L107$2.1K440,1020.0%
Aviragen Therapeutics IncCOM053761102$1.6K2,809,5310.0%
Digirad CorpCOM253827109$912354,1790.0%